--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About SPRY20260220P10
Pharmaceutical
ARS Pharmaceuticals, Inc., was incorporated under the laws of the State of Delaware on January 4, 2016. The company is a biopharmaceutical company focused on developing novel, potentially best-in-class product candidates, neffy for the emergency treatment of type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an innovative absorption enhancer called Intravail that allows neffy to deliver injection-like epinephrine absorption in small doses, easy to carry, easy to use, fast to administer and reliable nasal sprays.
